ATG Shareholders Approve Proxy Proposals At Annual Meeting.Business Editors FREMONT, Calif.--(BUSINESS WIRE)--July 17, 2000 At Friday's annual meeting of ATG ATG antithymocyte globulin. lymphocyte immune globulin (antithymocyte globulin equine, ATG, ATG equine, LIG) Atgam Pharmacologic class: Immunoglobulin Therapeutic class: Immunosuppressant Inc. (Nasdaq:ATGC ATGC Adenine,Thymine, Guanine, & Cytosine ATGC Asiantaeth Trwyddedu Hywyr A Cherbydau (Welsh: Driver and Vehicle Licensing Agency, UK) ), a leading provider of low-level radioactive and low-level mixed waste treatment services, shareholders overwhelmingly approved all proxy proposals, including the election of six directors to the company's board and an increase in the number of authorized shares Authorized shares Number of shares authorized for issuance by a firm's corporate charter. of capital stock from 21 million shares to 50 million shares. Eight million of these shares will be designated preferred stock Stock shares that have preferential rights to dividends or to amounts distributable on liquidation, or to both, ahead of common shareholders. Preferred stock is given preference over common stock. Holders of preferred stock receive dividends at a fixed annual rate. issuable in one or more series. "We have the right strategy in place to produce an improved second half in 2000 and a robust 2001," Doreen Chiu, president and chief executive officer of ATG, told shareholders. "We are expanding our production capacity, reducing costs by streamlining our operations, and continuing to win significant treatment contracts." The six directors elected to the company's board are: -- Doreen M. Chiu - President, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Chairman of the Board of ATG. -- Frank Y. Chiu - Executive Vice President of ATG. -- George Doubleday II - Chairman of the InnerAsia Group, a family of companies with interests in international tourism, trade and manufacturing. -- David F. Chan - Vice Chairman of American Safari Cruises, an upscale yacht cruising company in Seattle, Wash. -- David R. Sebastian - President of Sebastian & Associates, a financial advisory and investment banking consulting company Noun 1. consulting company - a firm of experts providing professional advice to an organization for a fee consulting firm business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a . -- James E. Thomas - Founder and President of Westmark Financial Company, an equipment leasing company based in Bellevue, Wash. About ATG Inc. ATG Inc. is a radioactive and hazardous waste Hazardous waste Any solid, liquid, or gaseous waste materials that, if improperly managed or disposed of, may pose substantial hazards to human health and the environment. Every industrial country in the world has had problems with managing hazardous wastes. management company that offers comprehensive thermal and non-thermal solutions for low-level radioactive and low-level mixed waste generated by commercial entities such as nuclear power plants, medical facilities and research institutions, both in the United States and overseas, and by the U.S. Departments of Defense and Energy. Certain statements contained in this news release may be deemed to be forward-looking statements under federal securities laws, and ATG, Inc. intends that such forward-looking statements be subject to the safe-harbor created thereby. Such forward-looking statements relate to: i) ATG producing profitable quarters in the second half of 2000; ii) ATG's efforts to expand its production capacity; iii) ATG's efforts to streamline its operations; and iv) ATG continuing to win treatment contracts, both domestically and internationally. ATG cautions that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements herein. Such factors include, but are not limited to: a) market acceptance of ATG's treatment processes; b) the Company's perception of the market for its services; c) the ability of ATG to sustain cost-saving activities; d) the Company's ability to sustain and manage its growth; e) ATG's ability to successfully win additional treatment contracts in the future; and other risks as detailed in ATG's annual report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , quarterly report on Form 10-Q Form 10-Q See 10-Q. , and other filings from time to time with the Securities and Exchange Commission. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion